Memantine enhances the inhibitory effects of naltrexone on ethanol consumption

European Journal of Pharmacology

Volumn 584, Issue 2-3, 2008, Pages 352-356

  Kuzmin, Alexander ^a   Stenback, Tove ^a   Liljequist, Sture ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Ethanol; Memantine; Naltrexone; Reward; Self administration

Indexed keywords

MEMANTINE; NALTREXONE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; MALE; MEMANTINE; MODELS, ANIMAL; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 41249101375     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.015     Document Type: Article

References (33)

1. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., Gastfriend D.R., Hosking J.D., Johnson B.A., LoCastro J.S., Longabaugh R., Mason B.J., Mattson M.E., Miller W.R., Pettinati H.M., Randall C.L., Swift R., Weiss R.D., Williams L.D., and Zweben A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295 (2006) 2003-2017
2. Bienkowski P., Stefanski R., and Kostowski W. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol. Eur. J. Pharmacol. 314 (1996) 277-280
3. Bisaga A., and Evans S.M. Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology 172 (2004) 16-24
4. Danysz W., Parsons C.G., Kornhuber J., Schmidt W.J., and Quack G. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci. Biobehav. Rev. 21 (1997) 455-468
5. Davidson D., and Amit Z. Effects of naloxone in limited-access ethanol drinking in rats. Alcohol. Clin. Exp. Res. 20 (1996) 664-669
6. Dimpfel W., Spuler M., Koch R., and Schatton W. Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology 18 (1987) 212-218
7. Feeney G.F., Connor J.P., Young R.M., Tucker J., and McPherson A. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Alcohol. Alcohol 41 (2006) 321-327
8. Froehlich J.C., Harts J., Lumeng L., and Li T.K. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol. Biochem. Behav. 35 (1990) 385-390
9. Heyser C.J., Moc K., and Koob G.F. Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28 (2003) 1463-1471
10. Hölter S.M., Danysz W., and Spanagel R. Evidence for alcohol anti-craving properties of memantine. Eur. J. Pharmacol. 314 (1996) R1-R2
11. Hubbell C.L., Czirr S.A., Hunter G.A., Beaman C.M., LeCann N.C., and Reid L.D. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3 (1986) 39-54
12. Hundt W., Danysz W., Holter S.M., and Spanagel R. Ethanol and N-methyl-d-aspartate receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology 135 (1998) 44-51
13. Kiefer F., Jahn H., Tarnaske T., Helwig H., Briken P., and Holzbach R. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry 60 (2003) 92-99
14. Kornhuber J., and Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man. Neurosci. Lett. 195 (1995) 137-139
15. Kotlinska J., and Liljequist S. The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol. Eur. J. Pharmacol. 332 (1997) 1-8
16. Kranzler H.R. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol. 35 (2000) 537-547
17. Krupitsky E.M., Neznanova O., Masalov D., Burakov A.M., Didenko T., Romanova T., Tsoy M., Bespalov A., Slavina T.Y., Grinenko A.A., Petrakis I.L., Pittman B., Gueorguieva R., Zvartau E.E., and Krystal J.H. Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am. J. Psychiatry 164 (2007) 519-523
18. Krystal J.H., Petrakis I.L., Webb E., Cooney N.L., Karper L.P., Namanworth S., Stetson P., Trevisan L.A., and Charney D.S. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch. Gen. Psychiatry 55 (1998) 354-360
19. Krystal J.H., Petrakis I.L., Mason G., and D'Souza D.C. NMDA glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol. Ther. 99 (2003) 79-94
20. Kuzmin A., Kreek M.J., Bakalkin G., and Liljequist S. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking. Neuropsychopharmacology 32 (2007) 902-910
21. O'Malley S.S., Krishnan-Sarin S., Farren C., Sinha R., and Kreek M.J. Naltrexone decreases craving and alcohol self-administration in alcohol dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology 160 (2002) 19-29
22. Pantev M., Ritter R., and Görtelmeyer R. Clinical and behavioural evaluation in long-term care patients with mild to moderate dementia under memantine treatment. Zeit. Gerontol. Psychiatry 6 (1993) 103-117
23. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38 (1999) 735-767
24. Pickering C., and Liljequist S. Cue-induced behavioural activation: a novel model of alcohol craving?. Psychopharmacology 168 (2003) 307-313
25. Quack G., Hesselink M., Danysz W., and Spanagel R. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover (Gen. Sect.). J. Neural Transm. 46 (1995) 97-105
26. Samson H.H., and Doyle T.F. Oral ethanol self-administration in the rat: effect of naloxone. Pharmacol. Biochem. Behav. 22 (1985) 91-99
27. Schmidt W.J., Zadow B., Kretschmer B.D., and Hauber W. Anticataleptic potencies of glutamate antagonists. Amino Acids 1 (1991) 225-237
28. Shelton K.L., and Balster R.L. Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA antagonists. Behav. Pharmacol. 5 (1994) 441-451
29. Spanagel R., and Zieglgansberger W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol. Sci. 18 (1997) 54-59
30. Spanagel R., Hölter S.M., Allingham K., Landgraf R., and Zieglgansberger W. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur. J. Pharmacol. 305 (1996) 39-47
31. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 876-880
32. Wenk G.L., Danysz W., and Mobley S.L. MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis. Eur. J. Pharmacol. 293 (1995) 267-270
33. Wolffgramm J., and Heyne A. From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat. Behav. Brain Res. 70 (1995) 77-83